Matica Bio Secures Commercial Manufacturing Deal with U.S. Biotech Company

Matica Bio Secures Commercial Manufacturing Deal with U.S. Biotech Company

COLLEGE STATION, Texas, Sept. 15, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector manufacturing for cell and gene therapies, today announced a strategic commercial manufacturing agreement with a…

Matica Bio Inks Manufacturing Deal with U.S. Biotech Company

Matica Biotechnology, a CDMO specializing in viral vector manufacturing for cell and gene therapies, reports that it signed a strategic commercial manufacturing agreement with a clinical-stage biotech company in the U.S. Matica officials say the partnership marks a significant milestone as Matica Bio initiates GMP production of viral vectors to support the development of a novel advanced therapy targeting a serious and underserved disease area. …